The startup bug has hit the world of biotechnology, and the latest victim is a business that is building a “super glue,” coincidentally, for bug-combating vaccines. SpyBiotech — a startup spun out of Oxford University that has developed a way to bond antigens to viruses and other particles to make vaccines — has announced £4 million ($5 million) in funding. Read More

Source: News